For research use only. Not for therapeutic Use.
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1].
| Catalog Number | I043754 |
| CAS Number | 679818-59-8 |
| Purity | ≥95% |
| Reference | [1]. Sanford M, McCormack PL. Ofatumumab. Drugs. 2010;70(8):1013-1019. |
